chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sleepy; exhausted; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleepy), FATIGUE (exhausted), CHILLS (chills) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     Concurrent medical conditions included Diabetes, Blood pressure high and Hypothyroidism. Concomitant products included LOSARTAN for Blood pressure high, TIRZEPATIDE (MOUNJARO) and INSULIN for Diabetes, THYROID (ARMOUR THYROID) for Hypothyroidism.    On 01-Oct-2023, the patient received third dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 02-Oct-2023, the patient experienced SOMNOLENCE (sleepy), FATIGUE (exhausted), CHILLS (chills) and HEADACHE (headache). At the time of the report, SOMNOLENCE (sleepy), FATIGUE (exhausted), CHILLS (chills) and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Patient had a total of 3 Moderna COVID-19 vaccine so far. The previous vaccine was administered about a year ago, but patient could not be sure. Patient did not find her vaccination card. On 02Oct2023 patient started having chills and spent 2 days in bed. Patient did not even get up to eat. Patient still felt very sleepy, slight headache and exhausted. Patient did not have other vaccines within the last 4 months.  Treatment medications were not reported.
ADMINISTRATION ERROR : Pt. received the Meningococcal B (Bexsero) instead of the Meningococcal Conjugate (Menactra)
Got shots on 8-18-22 for MCV4 and Tdap and is now covered with a full body rash.     Complained of legs aching 2 weeks after his shots, on 9/1/22.  That is not unusual for him, since he is rapidly growing taller.   But  then on 9/2/22 he woke up with myalgias in the arms and legs.   Mom encouraged him to drink water and go to school.  Didn't feel well.   He came home mid morning and slept all afternoon.  Subjective fever.  Stomach upset without vomiting.  Anorexia.    Then on 9/3/22 he woke up with spots.   Started on his chest.  After the rash appeared, the other symptoms went away.  He now feels pretty good.  No more muscle aching or fatigue.  He hasn't required any medications to treat these symptoms.  Rash progressed over a few days, worst on 9/6/22.   Came in to clinic for evaluation on 9/7/22.  The rash eventually spread to his arms and legs and became bright red.  It's itchy only when he scratches it.
high fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (high fever) and CHILLS (chills). At the time of the report, PYREXIA (high fever) and CHILLS (chills) outcome was unknown.            Concomitant medications were not reported.   No treatment details were reported.
so sick didn't known I was in this world, almost killed; Initial information was received on 28-Oct-2020 and follow-up information received on 01-Dec-2020 regarding an unsolicited valid serious case from a consumer via social media.  This case involves a patient (unknown demography) who was sick and ended up in hospital (illness), while the patient received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was so sick that didn't know was in this world and ended up in hospital (illness) (unknown latency) (serious) following the administration of INFLUENZA VACCINE.   The patient thought there was something in it that almost killed to the patient. It was also reported that the vaccine put the patient in hospital every time after taking it.  Details of laboratory data were not reported.  Corrective treatment was unknown.  At the time of report, the event outcome was unknown.  Information on the batch number was requested.; Sender's Comments: This was a poorly documented social media case received from social media involves a patient (unknown demography) who had illness and  hospitalized after receiving INFLUENZA VACCINE (unknown manufacturer). Time to onset is unknown. Additional information regarding patient's relevant medical history, health condition at time of vaccination and laboratory tests ruling out other alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.
At the time of the injection, I had numbness in my left fingertips, and my tongue was bitter/burning for few minutes. The Doctor in place informed that it was a normal reaction.   Everything was going well until I went to sleep. I woke up in panic due to not being able to breath. I felt like my brain, face, eyes, and nose were swelling. My chest was compressed. Then I remembered I didn't take any medication; therefore, I took two Advil. After and hour, I noticed that by sitting or walking , I began to feel better.  I went back to sleep in a seated position around 4:30.  Not sure if I want to take the 2nd dose. I'm frighten. Have an appointment with my Doctor on March 22nd.
This spontaneous report as received from a Licensed Practical Nurse via field employee refers to a female patient of unknown age. ON 21-SEP-2015 the patient was vaccinated with GARDASIL 9 dose 1. On 22-SEP-2015, the patient experienced fever, 102F, after receiving the first dose of GARDASIL 9. Patient sought medical attention by calling physician's office. The outcome of the event was unknown. No product quality complaint was involved. Additional information has been requested.
This case was reported in a literature article and described the occurrence of respiratory distress in a 2-month-old male subject who was vaccinated with DTPA-IPV-HIB (manufacturer unspecified), Poliomyelitis vaccine (manufacturer unspecified) and Hepatitis B vaccine (manufacturer unspecified). On an unspecified date, the subject received unspecified dose of DTPA-IPV-HIB (unknown route, unknown injection site). After vaccination, the subject developed respiratory distress, seizure-like stiffening, and fever. He was hospitalized for 5 days with an extensive negative work up. Two months after this event, the subject received unspecified dose of Poliomyelitis vaccine (unknown route, unknown injection site). Immediately after administration, the subject developed lethargy, a full body macular papular rash and fever. Three weeks later he was hospitalized for respiratory distress, and fever following the Hepatitis B vaccine (unknown route, unknown injection site). The subject had not been vaccinated since these episodes. Currently, standardized testing for ingredients in vaccines is not available. Skin testing with the vaccine was offered. At the time of reporting the outcome of the events was unspecified. Reactions to vaccines can be local or systemic and immediate or delayed. Decision to revaccinate should be made on an individual basis, depending on the importance of revaccination and nature of previous reaction.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. No adverse reactions were reported by patient.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because her facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment at this time. It was reported that no adverse reactions were reported by any patients. Reporter does not have details on how many patients were impacted or any information on patients.
This spontaneous case was reported by an other health care professional and describes the occurrence of SINUS CONGESTION (sinus congestion), VACCINATION SITE PRURITUS (injection site reaction with itching, redness, and swelling about walnut size), FATIGUE (felt tired), MYALGIA (achy all over) and VACCINATION SITE ERYTHEMA (injection site reaction with itching, redness, and swelling about walnut size) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Fatigue (fatigued and depressed as her mother had passed away on 21DEC2020), Depressed state and Surgery on 07-Dec-2020. Concurrent medical conditions included UTI and Blood pressure high. Concomitant products included VALSARTAN for Blood pressure high, LEVOTHYROXINE and SIMVASTATIN. On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced VACCINATION SITE PRURITUS (injection site reaction with itching, redness, and swelling about walnut size), FATIGUE (felt tired), MYALGIA (achy all over), VACCINATION SITE ERYTHEMA (injection site reaction with itching, redness, and swelling about walnut size) and VACCINATION SITE SWELLING (injection site reaction with itching, redness, and swelling about walnut size). On an unknown date, the patient experienced SINUS CONGESTION (sinus congestion). On 02-Jan-2021, VACCINATION SITE PRURITUS (injection site reaction with itching, redness, and swelling about walnut size), FATIGUE (felt tired), MYALGIA (achy all over), VACCINATION SITE ERYTHEMA (injection site reaction with itching, redness, and swelling about walnut size) and VACCINATION SITE SWELLING (injection site reaction with itching, redness, and swelling about walnut size) had resolved. At the time of the report, SINUS CONGESTION (sinus congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided as such but the patient stopped taking Simvastatin and Antibiotics.   This case was linked to MOD-2021-020998 (Patient Link).
Pt has localized allergic reaction in the arm. Swollen, pain, redness in the area following PNEUMOVAX 23 vaccination in the left arm. Pt was put on antibiotic and a MEDROL dose pack.
Sore arm shortly after vaccine. Fatigue in afternoon/evening of vaccine. Headache the two days following vaccine. Itchy rash on third and fourth day following vaccine
Initially severe myalgia and arthralgia on Day #2, which resolved.  Day #5 developed heart pounding, palpitations, tightness in chest and throat, decreased exercise tolerance.
My second vaccine for Pfizer was on 1/26/21. On 4/10/21, I tested positive for Covid 19, with a confirmed positive PCR on 4/11/21.
I have a long history of chronic illness since 1998. 2006 Optic neuritis . 6 neurological attacks since 2006 including this one.- riggered by pharma, sun/herbals, surgery and now the vaccine. I had the shot on 6:15 pm on April 26, by 10:00 I was feeling brain fogged.  During the night I felt head pressure/eye pressure and head/neck tremor-total insomnia.  By next day I was weak in mylegs all over, muscle twitching, jerking. Other symptoms are loss of proprioception and coordination, weakness, cogntive, speech stuttering, involuntary jerking/twitching, eye pressure, band across left side of head to eye more pronounced, dizzy/sick feeling in head, etc. It's been 12 weeks and I've had some improvement but still very sick.  Past neurological attacks have taken me 2 years to recover from but not back to baseline.  I am still undiagnosed but I have visible optic nerve damage and last year nerve conduction test showed some nerve damage.  I'm able to do a fraction of what I could before the vaccine.  I have a friend with history of Guillane barre and several autoimmune disease-she also suffered a neurological attack from pfizer vaccine, so I'm wondering if we are outliers or not?  Another friend with MS got very ill neurlogically after her 2nd Moderna shot.
Patient developed rash on neck, face on 2/9. Also had some shortness of breath and "watery eyes" on 2/8. Rash on inner arms, back, chest,  per nurse. Took BENADRYL 50mg with minimal improvement.
became ill 28Jan- T of 104, cold, cough & congestion, was not ill on the 23rd. Still ill 1Feb91
I took the first dose of the Pfizer vaccine on 5/4/2021. On 5/5/2021, I began experiencing shortness of breath, my chest was very tight, and I felt like someone was sitting on my chest. I felt like I was having an out of body experience and didn?t feel well. This continued until  5/14/2021 and seemed to resolve, but returned with a vengeance on 5/21/2021. The shortness of breath was much much worse and so was the tightness and pressure in my chest. I also had ringing in my ears. The day I took the vaccine (on 5/4/2021), my period had started, but stopped that day and didn?t return until 28 days later. I saw my doctor and he ordered an EEG and a stress echo test. The EEG returned normal, but I am waiting to go in for the stress echo test. I do not plan on taking the second dose because I?m very afraid of what might happen to me if I do. I am in excellent health and do not suffer from allergies. These side effects were awful! I didn?t start feeling better until  the first week of June. I don?t know if these symptoms will return. I still have ringing in my ears that comes and goes.
On 03/18/2021 began to itchy and pink Left upper arm. on 03/19/2021 became itchier and pinker and slightly warm to touch. Visit to urgent care. Diagnosis Cellulitis. put on Elcon cream and oral Keflex. On 03/20/2021 got worse. On 03/21/2021 left arm redder and extended one to two inches above shoulder and one to two inches below elbow. Involved are now clearly elevated from normal skin. About 2 inches above left elbow it was now close to encircling arm for about 3 inch length. on 03/22/2021 no change. Started with slight daily improvement on 03/23/2021, until resolved on approx. 03/28/2021.
10 y/o male administered 0.3 mL of Pfizer 12+ y/o COVID vaccine.  Patient was observed and no adverse reaction during 15 minute waiting period post vaccine administration.  Patient's parents notified by Medical Director and discussed monitoring steps.  Medical Director counseled parents to seek emergency room/urgent care/patient's pediatrician for monitoring going forward should adverse reaction occur.
LIGHTHEADEDNESS, FOLLOWING DONATION, AND IMMUNIZATION. DNR SAT IN CHAIR FOR 5 MINUTES, POWERADE GIVEN 16.9 OZ., RECOVERED.
DTaP was given in left deltoid muscle on 4-1-04. The mother came by & told nurse her arm swelled real big, was red & fevered. I took her to the ER on Sun & they gave her Benadryl. I've been giving her Benadryl & Motrin. "It's not as big today as it was."  The mother did not bring the pt & was the the health department needed to see the arm. Mother said "she can't today she has to go find birth certificate."
Shortness of breath, rapid heart beat, fluttering heart, mild dizziness. Symptoms seem to be diminishing.
Information has been received from a physician concerning a 15 year old female who on 16-AUG-2007 was vaccinated with Gardasil.  Concomitant therapy included Tdap and MENACTRA.  On 16-AUG-2007 the patient fainted.  Unspecified medical attention was sought.  On 16-AUG-2007, the patient recovered.  Additional information has been requested.
A report has been received from a Health Professional concerning a 4 year old, female patient. The relevant history and concomitant drugs of patient were not reported. The patient had been receiving nasal FLUMIST QUADRIVALENT (intranasal) started on 27-Sep-2013. The patient was tested for Flu A on 19-Dec-2013. She was not hospitalized, but was treated with TAMIFLU. It was reported that 5 patients were tested positive for Flu. This patient was one among them. The outcome of the event of flu A was unknown. The reporter considered event of flu A to be non-serious. Laboratory values are available.
No injection site or system reaction for first 7 days post vaccine, on day 8 patient noted raised red rash/hive at injection site. No pain, no pruritis, no blisters or streaking. No other symptoms at all.  Advised to use ice pack, OTC Tylenol or ibuprofen for pain and swelling, and cetirizine for itching.  If site becomes more painful, very itchy, blisters develop, or any systemic symptoms such as trouble breathing, etc, seek immediate medical attention.
Approximately 1 minute after vaccination, patient fell forward onto floor and severed lip. Immediately began to twitch.  Patient appeared to be having seizure-like movements similar to absence seizure.  She was not verbally responsive however, patient was breathing spontaneously. The patient was moved from the floor into a chair after 5 minutes and was able to maintain eye contact. It took her approximately 10 minutes to respond verbally to her mother's commands.  The patient and parent were in the examination room more than 30 minutes after the incident, however patient remained sluggish.
Low platelet count of 11000; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET COUNT DECREASED (Low platelet count of 11000) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced PLATELET COUNT DECREASED (Low platelet count of 11000). At the time of the report, PLATELET COUNT DECREASED (Low platelet count of 11000) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, Platelet count: 11000 Inconclusive. On 17-Feb-2021, Platelet count: 59000 Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.. Treatment information include steroids.
Patient became lethargic with labored breathing and decreased oxygen saturation. Expired after sent out of facility for treatment.
I had pretty bad chills and a headache the night of that lasted the whole night and part of the next day. It made it very hard to sleep
Fatigue, malaise, jt. pain and swelling hands and ankles. Fatigue and malaise lasted approximately 72 hours. Pain and swelling lasted approximately 15 hours. Took Ibuprofen x 2-3 doses.
Rash began on torso on AM of 1-3-06.  Denies itch.  Rash is describe crops of pink papules-some vesicles-some spots on neck, near ears.  No oral lesions.  Placto documentation.
Felt like hroat was closing; Couldn't breathe; This case was reported by a nurse via sales rep and described the occurrence of throat constriction in a female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2019-2020 season) for prophylaxis.   On an unknown date, the patient received the 1st dose of Fluarix Quadrivalent 2019-2020 season .5 ml. On an unknown date, less than a year after receiving Fluarix Quadrivalent 2019-2020 season, the patient experienced throat constriction and difficulty breathing. On an unknown date, the outcome of the throat constriction and difficulty breathing were unknown.   It was unknown if the reporter considered the throat constriction and difficulty breathing to be related to Fluarix Quadrivalent 2019-2020 season.  Additional details were provided as follows: The age at vaccination was not reported but could be between 36 or 37 years. The reporter stated that the patient felt like her throat was closing and she could not breathe after vaccination. The reporter consented to follow up.
Information has been received from a father concerning his 9 year old daughter who on 23-JAN-2007 was vaccinated with a first dose of GARDASIL. There was no concomitant medication. On 11-APR-2007 she was vaccinated with a second 0.5ml dose GARDASIL. Subsequently, the patient experienced Vitiligo. On 04-FEB-2008 was vaccinated with a third dose of GARDASIL. The patient sought unspecified medical attention. The patient underwent unspecified "labs" (result not reported). At the time of the report the Vitiligo was not recovered. Additional information has been requested.
Three minutes after receiving a Janssen vaccine, patient was noted by this RN to be unresponsive in his chair located in the post vaccine observation area.  The following observations were noted.  His head was tilted back resting on the clinic trailer.  Body positioned, slumped in the chair.   His pupils were positioned back.  Unresponsive to verbal or tactile stimuli.  Respiration labored with an occasional agonal breath.  Infrequent twitching of body noted.  Patient was drooling, clear secretions.  Pallor was noted on this patient's face.  Time lapse for previous noted symptoms was one minute.  Vital signs were assessed.  Vital signs were normal.  BP 120/60, left arm, manual assessment cuff.  HR 56.  RR 18.  02 saturation 97 % on room air.   Blood glucose 97 mg./dl.  911 called for rescue.   Patient gradually regained conscious.  Patient vomited two times, small amount, clear secretions.  Rescue arrived.  Normal sinus rhythm.   Patient was alert and oriented x 3.  Refused transport to the hospital for evaluation.  Home with family driving him home.  Patient does not have a PCP.  Patient encouraged to call 911 if symptoms return.
PATIENT REPORTS SHE BEGAN TO EXPERIENCE A RASH AROUND HER WAIST, WHICH WORSENED, REQUIRING HER TO SEE HER PCP; SHE WAS PRESCRIBED A STEROID DOSE PACK; HER PHYSICIAN RULED OUT SHINGLES